A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer (Q43931585)
Jump to navigation
Jump to search
scientific article published in April 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer |
scientific article published in April 2002 |
Statements
1 reference
A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer (English)
1 reference
John Trachtenberg
1 reference
Marc Gittleman
1 reference
Christopher Steidle
1 reference
Winston Barzell
1 reference
William Friedel
1 reference
Dennis Pessis
1 reference
Nick Fotheringham
1 reference
Marilyn Campion
1 reference
Marc B Garnick
1 reference
Abarelix Study Group
1 reference
1 April 2002
1 reference
1 reference
167
1 reference
4
1 reference
1670-1674
1 reference
Identifiers
1 reference
1 reference